BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22713668)

  • 41. LASP1 in Tumor and Tumor Microenvironment.
    Hu Z; Wang X; Cui Y; Li C; Wang S
    Curr Mol Med; 2017; 17(8):541-548. PubMed ID: 29473505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypoxia-inducible microRNA-218 inhibits trophoblast invasion by targeting LASP1: Implications for preeclampsia development.
    Fang M; Du H; Han B; Xia G; Shi X; Zhang F; Fu Q; Zhang T
    Int J Biochem Cell Biol; 2017 Jun; 87():95-103. PubMed ID: 28412444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A.
    Chen Q; Wu K; Qin X; Yu Y; Wang X; Wei K
    J Cell Mol Med; 2020 Jan; 24(2):1626-1639. PubMed ID: 31793711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-133a acts as a tumor suppressor in lung cancer progression by regulating the LASP1 and TGF-β/Smad3 signaling pathway.
    Shen Y; Yang Y; Li Y
    Thorac Cancer; 2020 Dec; 11(12):3473-3481. PubMed ID: 33074595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression.
    Dejima T; Imada K; Takeuchi A; Shiota M; Leong J; Tombe T; Tam K; Fazli L; Naito S; Gleave ME; Ong CJ
    Prostate; 2017 Feb; 77(3):309-320. PubMed ID: 27775154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upregulation of the long non-coding RNA PVT1 promotes esophageal squamous cell carcinoma progression by acting as a molecular sponge of miR-203 and LASP1.
    Li PD; Hu JL; Ma C; Ma H; Yao J; Chen LL; Chen J; Cheng TT; Yang KY; Wu G; Zhang WJ; Cao RB
    Oncotarget; 2017 May; 8(21):34164-34176. PubMed ID: 28404954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcription factor AP-4 (TFAP4)-upstream ORF coding 66 aa inhibits the malignant behaviors of glioma cells by suppressing the TFAP4/long noncoding RNA 00520/microRNA-520f-3p feedback loop.
    Wang Y; Yang C; Liu X; Zheng J; Zhang F; Wang D; Xue Y; Li X; Shen S; Shao L; Yang Y; Liu L; Ma J; Liu Y
    Cancer Sci; 2020 Mar; 111(3):891-906. PubMed ID: 31943575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-192-5p inhibits migration of triple negative breast cancer cells and directly regulates Rho GTPase activating protein 19.
    Vajen B; Greiwe L; Schäffer V; Eilers M; Huge N; Stalke A; Schlegelberger B; Illig T; Skawran B
    Genes Chromosomes Cancer; 2021 Nov; 60(11):733-742. PubMed ID: 34296808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
    Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
    Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.
    Yu X; Zhang X; Dhakal IB; Beggs M; Kadlubar S; Luo D
    BMC Cancer; 2012 Jan; 12():29. PubMed ID: 22260523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.
    Wang Y; Dong L; Liu Y
    Cancer Biother Radiopharm; 2019 Oct; 34(8):529-536. PubMed ID: 31424277
    [No Abstract]   [Full Text] [Related]  

  • 56. MiR-449a promotes breast cancer progression by targeting CRIP2.
    Shi W; Bruce J; Lee M; Yue S; Rowe M; Pintilie M; Kogo R; Bissey PA; Fyles A; Yip KW; Liu FF
    Oncotarget; 2016 Apr; 7(14):18906-18. PubMed ID: 26934316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LASP-1, regulated by miR-203, promotes tumor proliferation and aggressiveness in human non-small cell lung cancer.
    Zheng J; Wang F; Lu S; Wang X
    Exp Mol Pathol; 2016 Feb; 100(1):116-24. PubMed ID: 26683818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer.
    Ma T; Liu H; Liu Y; Liu T; Wang H; Qiao F; Song L; Zhang L
    BMC Cancer; 2020 Oct; 20(1):998. PubMed ID: 33054738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer.
    Zhao Z; Li L; Du P; Ma L; Zhang W; Zheng L; Lan B; Zhang B; Ma F; Xu B; Zhan Q; Song Y
    Theranostics; 2019; 9(5):1401-1416. PubMed ID: 30867840
    [No Abstract]   [Full Text] [Related]  

  • 60. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.